You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-NHL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • regimen with BTK inhibitor +Anti-CD19 CAR T cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022

Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • BAFFR-CAR T cells
  • Duarte, California
    City of Hope Medical Center
Oct 18, 2022

B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • UCART20x22
  • CLLS52
  • Austin, Texas
    Sarah Cannon - St. David South Austin Medical Center
Dec 8, 2022

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • CD19x22 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Perth, Western Australia, Australia
        Linear Clinical Research Ltd
      Apr 20, 2023

      Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

      Not yet recruiting
      • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Mar 23, 2023

      B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

      Recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • Cincinnati, Ohio
        The Christ Hospital
      Apr 1, 2022

      Lymphoma, Non-Hodgkin Trial in China (DZD8586)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Beijing, Beijing, China
      • +5 more
      Apr 25, 2023

      Hematoma Trial in Beijing (CM355)

      Active, not recruiting
      • Hematoma
      • Beijing, China
        Beijing university cancer hospital
      Jan 10, 2022

      NHL, Leukemia Trial in Australia (ETH-155008)

      Recruiting
      • NHL
      • Leukemia
      • Adelaide, South Australia, Australia
      • +4 more
      Jun 8, 2022

      B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

      Not yet recruiting
      • B-cell Non-Hodgkins Lymphoma (B-NHL)
      • (no location specified)
      Jan 5, 2023

      Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)

      Recruiting
      • Non-Hodgkin's Lymphoma
      • ThisCART19A
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Apr 21, 2022

      B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma (B-NHL)
      • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
      • PIT565
      • (no location specified)
      Jun 13, 2022

      Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

      Not yet recruiting
      • Non Hodgkin's Lymphoma
      • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
      • +2 more
      • Beijing, China
      • +2 more
      Aug 23, 2023

      Severe COVID-19 Infection in CLL or B-NHL Who Received

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • +2 more
        • (no location specified)
        Apr 6, 2023

        CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

        Recruiting
        • CAR
        • +2 more
        • ThisCART19A with Dose Level 1
        • ThisCART19A with Dose Level 2
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Jan 18, 2023

        Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

        Recruiting
        • Relapsed or Refractory Non-Hodgkin's Lymphoma
        • Changsha, Hunan, China
        • +1 more
        Mar 13, 2023

        B-cell NHL, CLL Trial (CARCIK-CD19)

        Not yet recruiting
        • B-cell NHL
        • CLL
        • CARCIK-CD19
        • (no location specified)
        May 19, 2023